PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2109
https://www.valueinhealthjournal.com/article/S1098-3015(12)03823-5/fulltext
Section Title : Cancer
Section Order : 761
First Page : A421
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03823-5&doi=10.1016/j.jval.2012.08.2109
HEOR Topics :
Tags :
Regions :